Mediclinic International PLC (LON:MDC) had its price objective cut by Jefferies Group from GBX 833 ($10.87) to GBX 812 ($10.60) in a report released on Wednesday. They currently have a hold rating on the stock.
Several other research firms also recently issued reports on MDC. JPMorgan Chase & Co. reissued a neutral rating and issued a GBX 1,160 ($15.14) price target on shares of Mediclinic International PLC in a research report on Tuesday, August 23rd. Citigroup Inc. raised shares of Mediclinic International PLC to a buy rating and lifted their price target for the company from GBX 990 ($12.92) to GBX 1,150 ($15.01) in a research report on Tuesday, June 28th. Seven analysts have rated the stock with a hold rating and one has assigned a buy rating to the company’s stock. The company currently has a consensus rating of Hold and a consensus target price of GBX 964.43 ($12.59).
Shares of Mediclinic International PLC (LON:MDC) opened at 929.00 on Wednesday. The company’s market cap is GBX 6.85 billion. The stock has a 50 day moving average of GBX 1,001.92 and a 200-day moving average of GBX 961.15. Mediclinic International PLC has a 12 month low of GBX 794.50 and a 12 month high of GBX 1,219.00.
About Mediclinic International PLC
Mediclinic International plc, formerly Al Noor Hospitals Group plc, is a holding company. The Company operates as an international private healthcare provider. Its segments include Mediclinic Southern Africa, Mediclinic Switzerland, Mediclinic Middle East, United Kingdom and Corporate. It focuses on providing acute care and multidisciplinary healthcare services.
Receive News & Ratings for Mediclinic International PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mediclinic International PLC and related companies with MarketBeat.com's FREE daily email newsletter.